Gyeonggi-do, South Korea

I Seul Park

This inventor holds 1 USPTO granted patent. Top assignee: Hk Inno.n Corporation. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: I Seul Park: Innovator in Pharmaceutical Composition

Introduction

I Seul Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating gastrointestinal disorders.

Latest Patents

I Seul Park holds a patent for a pharmaceutical composition comprising a benzimidazole derivative compound. This invention provides a pharmaceutical composition for preventing or treating colitis, utilizing tegoprazan as an effective ingredient. His innovative approach addresses a critical need in the medical community.

Career Highlights

Park is associated with Hk Inno.n Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on patient care and treatment options.

Collaborations

Some of his notable coworkers include Jae Hee Cheon and Seung Won Kim, who contribute to the collaborative environment at Hk Inno.n Corporation.

Conclusion

I Seul Park's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for colitis. His work exemplifies the role of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…